Immune to Cancer: The CRI Blog
-
Honoring Hispanic Immunologists During National Hispanic Heritage Month
Immunotherapy is the most forward-thinking and promising treatment for many types of cancers. Outcomes for childhood cancers,… -
CRI Remembers Transformational Philanthropist, Chuck Feeney
The Cancer Research Institute mourns the loss of Charles “Chuck” Feeney, an Irish American entrepreneur and philanthropist… -
Prostate Cancer: A Unique and Common Cancer Affecting Men
Most cancers affect everyone, regardless of sex, race, age, and other factors. Prostate cancer, however, only affects… -
2021 William B. Coley Award Recipients Drs. Katalin Karikó and Drew Weissman Receive the 2023 Nobel Prize in Physiology or Medicine
On October 2 the Nobel Assembly at Karolinska Institute in Stockholm, Sweden, announced that the 2023 Nobel… -
CRI Received a 100% ‘Four-Star Charity’ Rating – Here’s Why That Matters
When people seek out nonprofits with missions that align with their values, it can be initially challenging… -
How CRI-Funded Scientists are Reducing and Guarding Against Childhood Cancers
A cancer diagnosis is always extremely difficult news for a patient and their family. It can be… -
Drs. Carl June and Michel Sadelain to Receive 2024 Breakthrough Prize in Life Sciences
CRI Scientific Advisory Council member Carl June, MD (University of Pennsylvania) and CRI Clinical Accelerator Advisor Michel… -
Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative
U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House… -
Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field
iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.